- Home
- QGEN vs CAG Comparison
QGEN vs CAG Comparison
Compare QGEN & CAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QGEN | CAG |
|---|---|---|
| Founded | 1986 | 1919 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 9.3B |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | QGEN | CAG |
|---|---|---|
| Price | $45.06 | $17.75 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 12 |
| Target Price | ★ $49.74 | $20.67 |
| AVG Volume (30 Days) | 1.2M | ★ 9.5M |
| Earning Date | 11-04-2025 | 12-19-2025 |
| Dividend Yield | 3.34% | ★ 7.89% |
| EPS Growth | ★ 331.20 | 73.36 |
| EPS | ★ 1.84 | 1.77 |
| Revenue | $2,070,781,000.00 | ★ $11,450,500,000.00 |
| Revenue This Year | $7.12 | N/A |
| Revenue Next Year | $6.13 | N/A |
| P/E Ratio | $24.59 | ★ $10.03 |
| Revenue Growth | ★ 5.32 | N/A |
| 52 Week Low | $37.63 | $16.60 |
| 52 Week High | $51.88 | $28.52 |
Technical Indicators
Market Signals| Indicator | QGEN | CAG |
|---|---|---|
| Relative Strength Index (RSI) | 42.22 | 55.48 |
| Support Level | $45.55 | $16.86 |
| Resistance Level | $47.48 | $17.35 |
| Average True Range (ATR) | 0.59 | 0.33 |
| MACD | -0.17 | 0.06 |
| Stochastic Oscillator | 11.63 | 79.02 |
Price Performance
Historical ComparisonAbout QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
About CAG ConAgra Brands Inc.
Conagra Brands is a packaged food company that operates predominantly in the United States (91% of fiscal 2025 revenue). Most of its revenue comes from frozen food, including brands like Marie Callender's, Healthy Choice, Banquet, and Birds Eye. Conagra also sells snacks, shelf-stable staples, and refrigerated food through brands like Duncan Hines, Hunt's, Slim Jim, Vlasic, Orville Redenbacher's, Reddi-wip, Wish-Bone, and Chef Boyardee. The company primarily sells through the US retail channel, with just 9% of fiscal 2025 revenue coming from international markets and 9% from foodservice.